Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “RADIOACTIVITY”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 433 records · Page 24Linked to original sources

Natural radioactivity of Miami soils.

An important part of man's radioactive environment is the natural radioactivity of soils. This radioactivity varies with soil type and withdepth in the soil profile. The relation between gross gamma activity and soil depth for a particular soil (Miami silt loam) is presented, together with a discussion of the contribution of K(40) and the uranium and thorium series and of the effects of fallout from bomb tests in increasing the radioactivity of a thin layer of surface soil.

Gamma Rays↗

[Sources of natural and artificial radioactive contamination in the marine environment].

Sources of natural and artificial radioactive contamination in the marine environment. The Chernobyl accident produced the most severe contamination of Europe, still detectable in environmental samples, but many other sources of artificial and natural radioactivity have produced a considerable impact on the environment and a risk for the public health. In this paper a review of the most important events or industrial processes that produced contamination of the European seas is presented; moreover, attention is paid to the situation of the coastal marine environment in Italy as regards the artificial radioactivity and the human enhanced radioactivity produced by non nuclear plants.

Air Pollutants, Radioactive↗

[Processing of liquid radioactive waste by RADON Industrial Research Association].

The authors present experience accumulated by "RADON" Industrial Research Association in treating liquid radioactive waste. According to the presentation, activities of "R ADON" Industrial Research Association develop in three directions--evolving technical means to purify radioactive waters in "RADON" Industrial Research Association, advancing mobile plants to purify radioactive waters in other institutions, elaborating new technologies for liquid radioactive waste purifications within numerous national and international projects and agreements with various organizations (including those associated with nuclear power stations and nuclear submarines).

Humans↗

Effect of radioactivity on stent-graft incorporation after endovascular treatment of aneurysms: An animal study.

Poor stent-graft (SG) incorporation into the vessel wall, following endovascular repair of abdominal aortic aneurysms (EVAR), can lead to endoleaks and SG migration. Low-dose radiation can prevent aneurysm recurrence after coil embolization, and has been associated with a "paradoxical" increase in neointima formation after stenting in a few studies. It was hypothesized that in situ beta radiation emitted from SG could improve its incorporation by preventing the persistence of circulating channels between the implant and the vessel wall and increasing neointima formation around the SG. Phosphorus 32 ((32)P, 200 or 400 kBq per SG (n = 6 each)) was ion implanted on the external surface of balloon-expandable SGs. Twelve radioactive and six non-radioactive SGs were deployed in iliac arteries of nine Mongrel dogs. Neointima formation inside the graft and the persistence of circulating flow through an artificial groove created during the endovascular procedure were assessed by follow-up imaging and by blinded, computerized histomorphometric analysis after animal sacrifice at 3 months. Occlusion occurred in four radioactive SGs. A lesser number of patent grooves was observed along high-activity SGs than along control SGs (1/3 versus 4/4). No difference in neointima formation was observed in radioactive and non-radioactive SGs. Alteration of external graft surface was observed after ion implantation. Ion implantation of (32)P on SGs does not seem to be a viable strategy to improve incorporation and prevent type-I endoleak after EVAR.

Aneurysm↗

Regional differences in the electrically stimulated release of endogenous and radioactive adenosine and purine derivatives from rat brain slices.

The release of both radioactive and endogenous purines was investigated in rat brain cortical, hippocampal and striatal slices at rest and following stimulation with electrical fields. Purines were labelled by incubating the slices with 3H-adenine. The purine efflux at rest and that evoked by electrical stimulation (10 Hz. 5 min) was analyzed by HPLC with ultraviolet absorbance detection. Both radioactive and endogenous purines in the effluent consisted mainly of hypoxanthine, xanthine, inosine and adenosine. No qualitative differences in the composition of the released purines were found in the three areas investigated. Electrical stimulation evoked a net increase in both radioactive and endogenous purine release. However the increase in 3H-adenosine following electrical stimulation was twice as large as that of endogenous adenosine. The electrically evoked release of both radioactive and endogenous purines was greatest in hippocampal slices and progressively smaller in cortical and striatal slices. In the three areas the addition of 0.5 microM tetrodotoxin to the superfusing Krebs solution brought about a similar (83-100%) reduction in evoked 3H-purine and endogenous purine release. Superfusion of the slices with calcium-free Krebs solution containing 0.5 mM EGTA reduced evoked release of 3H-purines by 58-60% and that of endogenous purine components by 54-89%. The results demonstrate similar characteristics for both radioactive and endogenous purine release but indicate that the most recently synthetized adenosine is the most readily available for release. The features of the electrically evoked purine release support a neuronal origin of adenosine and derivatives and are consistent with the hypothesis of discrete regional differences in adenosine neuromodulation.

Adenosine↗

Distribution of radioactivity and anthracycline-fluorescence in tissues of mice one hour after [14C]-labeled AD 32 administration. Evidence for tissue aglycone formation.

Levels of radioactivity and total anthracycline fluorescence in tissues of A/JAX mice were compared 1 h after IV administration of unlabeled or [14C]-labeled AD 32 (50 mg/kg). Highest levels of both fluorescence and radioactivity were found in the small intestine (including contents) and liver, a result consistent with the known hepatobiliary excretion of AD 32 and metabolites. Significant accumulations of radioactivity and fluorescence were found in kidney, spleen, large intestine (including contents), lung, and heart. Lesser levels were found in muscle and fat. Little radioactivity and fluorescence were found in brain. Liquid chromatographic analysis of extracts of small intestine and liver homogenates showed N-trifluoroacetyladriamycin (AD 41) as the major fluorescent species, and also revealed N-trifluoroacetyladriamycinol (AD 92) and occasional low levels of AD 32. In addition, there was a major peak of nonfluorescent radioactive material and two fluorescent nonradioactive signals (unknowns 1 and 2), indicative of cleavage of the radiolabel from the chromophore.

Animals↗

Distribution and elimination of (14C)-2-ethylhexyl acrylate radioactivity in rats.

The fate of (14C)-2-ethylhexyl acrylate was studied in adult male Wistar rats given an intravenous (i.v.) or intraperitoneal (i.p.) injection of 10 mg/kg (0.054 mmol/kg). The elimination of radioactivity from blood was bi-exponential, irrespective of the route of (14C)-2-EHA administration or the age (weight) of the rats. The first phase half-lives after i.v. and i.p. administration in 4-month-old rats were 30 and 60 min, in 7-month-old rats 115 and 130 min, respectively. The corresponding values for the slow-phase were 5 and 6 h, and 14 and 14 h. Elimination of the radioactivity from tissues followed a pattern similar to that seen for blood. More than half of the administered radioactivity was exhaled as carbon dioxide. Exhalation of unchanged (14C)-2-EHA accounted for only 0.05% (i.v.) or 0.3% (i.p.) of the initial dose of radioactivity. The radioactivity excreted in the urine within the first 24 h post-treatment accounted for 7% (i.p.) or 14% (i.v.) of the initial dose, and only 2% was excreted as thioethers.

Acrylates↗

Effect of aminooxyacetic acid on the release of preloaded [3H]GABA and radioactive metabolites from slices of developing mouse brain.

The release of [3H]gamma-aminobutyric acid (GABA) and its radioactive metabolites from slices of the cerebral cortex, cerebellum, striatum and brain stem of developing and adult mice was studied. The slices were incubated and superfused in the absence and presence of the GABA aminotransferase (GABA-T) inhibitor aminooxyacetic acid (AOAA). Exposure to 100 microM AOAA totally inhibited GABA-T and all radioactivity released from slices was in authentic GABA. In studies on developing brain the 10-microM concentration was also effective enough, except in cerebellar slices. In the absence of AOAA the major part of radioactivity spontaneously released from slices of adult cerebral cortex and cerebellum was tritiated water and still about one third part in the presence of 10 microM AOAA. Potassium stimulation induced only the release of radioactive GABA but not labeled metabolites in both presence and absence of AOAA. AOAA reduced the stimulation-induced release of GABA. It is recommended that the use of GABA-T inhibitors should be discontinued in release experiments. Then labeled GABA must be separated in the effluents from its radioactive breakdown products.

Acetates↗

Biliary excretion of radioactivity after intravenous administration of [3H]25-hydroxyvitamin D3 in man.

The biliary excretion of radioactivity after intravenous [3H]25-hydroxyvitamin D3 was studied in nine patients with T-tube bile drainage. The mean +/- SD 24-hr radioactivity excretion in T-tube bile expressed as a percentage of the administered dose was 6.7 +/- 2.9%; after correction for incomplete bile collection, the value obtained was 16.0 +/- 11.1%. Chloroform solubility of biliary radioactivity increased from 27.4 +/- 8.9% to 72.9 +/- 10.1% following incubation with beta-glucuronidase. High-performance liquid chromatographic analysis of chloroform extracts of bile revealed that most of the eluted radioactivity was more polar than [3H]25-hydroxyvitamin D3. No free [3H]25-hydroxyvitamin D3 was demonstrated. Thus in man, most of the biliary radioactivity excreted following [3H]25-hydroxyvitamin D3 is in the form of water-soluble compounds, mainly glucuronides. However, our results suggest that glucuronides of metabolites other than 25-OHD3 are predominantly formed.

Adult↗

Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?

From 1964 to 1989, bone metastases were found in 28 of 600 patients operated on for differentiated thyroid carcinoma. Bone metastasis was the presenting symptom in 15 (54%) patients, was detected from the initial symptom in 4 (14.5%) patients, and occurred subsequently in 9 (32%) patients, with an average lag time of 4.5 years after surgical treatment. Pathological pattern of the thyroid cancer was follicular in 26 (93%) patients and papillary in 2 (7%) patients. Bone metastatic involvement was multiple in 21 (75%) patients and associated with other synchronous or metachronous distant metastases in 13 (46%) patients, especially in the lung (10 patients) or the brain (3 patients). The primary treatment of thyroid carcinoma was total thyroidectomy in all 28 patients, with additional modified neck dissection in 8 patients. All 15 patients presenting with symptoms had bone metastases demonstrated by x-ray studies. Six of the bone metastases only took up radioactive iodine 6 weeks after total thyroidectomy, as did 2 of 4 bone metastases detected at initial observation and 4 of 9 metachronous bone metastases. All 12 patients with functioning bone metastases were given radioactive iodine therapy; 4 of the metastases were surgically resected. Only 2 patients with bone metastases showed a complete response after an ablative dose of I-131; none of the metastases had been demonstrated by x-ray studies. Radioactive iodine therapy cures no more than 17% of patients with bone metastases taking up radioactive iodine and 7% of all patients with bone metastases. All patients cured of bone metastases were given radioactive iodine, either alone, or combined with other treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Adenocarcinoma↗

Lipogenesis in the developing brain: utilization of radioactive leucine, isoleucine, octanoic acid and beta-hydroxybutyric acid.

Incorporation of radioactivity from intracranially injected radioactive leucine, isoleucine (ketogenic amino acids), octanoic acid and beta-hydroxybutyric acid into the brain lipids of 15 to 16 day-old rats was examined. The results showed that radioactivity from all the above precursors was incorporated into brain lipids. Radioactivity from injected isoleucine was incorporated into odd numbered fatty acids indicating an alternate pathway to alpha-oxidation for the biosynthesis of these fatty acids in the brain. For some as yet unclear reasons, a substantial portion of the radioactivity from injected octanoic acid was incorporated into free fatty acids. Utilization of these compounds for providing carbon for lipogenesis during development under unstressed normal conditions is discussed.

Animals↗

Binding and clearance of radioactive adrenaline and noradrenaline in sheep blood.

An understanding of the conditions influencing protein binding of catecholamines (CAs) is important in studying their metabolic effects. Unfortunately, reports on plasma protein binding of CAs are scarce, conflicting and mainly performed in vitro. The aim of our in vivo and in vitro studies was to investigate binding and clearance of radioactive adrenaline (epinephrine) ((3)H-A), noradrenaline (norepinephrine) ((3)H-NA) and their metabolites in sheep blood. The time course of the radioactivity in the blood after intravenous injection of (3)H-A and (3)H-NA (3.7 MBq each) in 4 sheep (2 of each sex; total of 8 administrations) was determined. Blood samples were taken from the jugular vein. The highest radioactivity was observed in the first sample (5 min) following injection. Radioactivity showed a biphasic disappearance. An initial stage, in which radioactivity decreased rapidly (within 1 h) after the injection, was followed by a slow stage, lasting for up to 1 month, until background levels were reached. In vitro results indicated that NA and A were present not only in plasma (70%) but also in the erythrocytes (30%; mainly bound to haemoglobin). Sephadex G-25 gel filtration revealed that from the plasma fraction about 15% was strongly bound to proteins (mainly albumin). These results demonstrate that previous experiments in this field have overestimated the percentage of CAs bound to plasma proteins, because binding to haemoglobin was previously not known. In the future, efforts should be made to characterize the adduct products of CAs and establish an assay to determine them in vivo. If this could be achieved, it would yield a valuable tool for measuring the stress experienced for a longer period.

Albumins↗

[Radioactive stents: problems and potential solutions].

BACKGROUND: The implantation of radioactive stents was the first procedure of a coronary brachytherapy in Europe examined in multicenter clinical trials. PROBLEMS OF RADIOACTIVE STENTS: After more than 400 patients with radioactive stents were analyzed, it became clear that overall restenosis rates were not reduced. A new phenomenon called the "edge effect" or "candy-wrapper" effect was discovered, which later was also described for catheter-based brachytherapy. Currently, the implantation of radioactive stents for the prevention of restenosis cannot be recommended. DRUG ELUTING STENTS: Although technical improvements of radioactive stents are theoretically possible, novel drug coated stents may overcome any future research of stent-based radiotherapy. Drug eluting stents induce antiproliferative effects beyond the stent margins. Edge effects were not observed in preliminary trials. However, long-term results need to be awaited.

Angioplasty, Balloon, Coronary↗

A rapid assay for activity of phospholipase A2 using radioactive substrate.

A rapid method for the assay of phospholipase A2 has been developed using a radioactive substrate, L-alpha-dipalmitoyl-(2-[9,10(N)-3H]palmitoyl)-phosphatidylcholine. The substrate diluted with cold carrier (1 mM) is dissolved in 80% ethanol containing 25 mM sodium deoxycholate. The enzymatic reaction is performed in 1.0 ml 0.1 M glycine-NaOH buffer, pH 9.0, containing 2 mumol CaCl2, 10 micrograms bovine serum albumin, 2.5 mumol sodium deoxycholate, 0.01 unit (or less) phospholipase A2, and 40-100 nmol substrate. The enzymatic reaction is terminated by adding 0.2 ml 5% Triton X-100 solution containing 40 mumol EDTA. The product of the enzymatic reaction, radioactive palmitic acid, is extracted by 10 ml hexane containing 0.1% acetic acid in the presence of anhydrous sodium sulfate (0.5 g/ml). Activity of phospholipase A2 is directly determined from the radioactivity in the hexane extract. The present method achieves a quick separation of the radioactive product, [3H]palmitic acid, from the radioactive substrate, L-alpha-dipalmitoyl-(2-[3H]palmitoyl)-phosphatidylcholine, without the need of separation by TLC.

1-Propanol↗

Use of actin-bound adenosine 5'-diphosphate as a method to determine the specific 32P-radioactivity of the gamma-phosphoryl group of adenosine 5'-triphosphate in a highly compartmentalized cell, the platelet.

Determination of the specific 32P-radioactivity of cytoplasmic ATP in 32P-Pi-labeled platelets is complicated by the presence of a large pool of metabolically inactive, granule-stored nucleotides. Moreover, our data show that the specific 32P-radioactivity of cytoplasmic ATP is severely underestimated when determined in platelets after the complete secretion of granule-stored nucleotides, possibly due to isotopic dilution with granule-stored phosphate. As F-actin-bound ADP is ethanol-insoluble, this pool can be readily separated from the other nucleotide pools in platelets. Here we show that the specific 32P-radioactivity of F-actin-bound ADP accurately reflects that of the gamma-phosphoryl group of cytoplasmic ATP. During uptake of 32P-Pi by human platelets the specific 32P-radioactivity of F-actin-bound ADP equals that of the monoester phosphates of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate, which are in metabolic equilibrium with cytoplasmic ATP. Therefore, this method enables the determination of the specific 32P-radioactivity of the gamma-phosphoryl group of cytoplasmic ATP in platelets even under short-term labeling conditions.

Actins↗

The effects of glibenclamide on rat islet radioactive nucleotide efflux, ATP contents and respiratory rates.

In order to assess the effects of sulphonylurea on islet function, changes in radioactive nucleotide efflux, ATP contents and oxygen uptake of low or high glucose cultured rat islets in response to glibenclamide were determined. It was observed that: (1) low glucose cultured islets displayed a prompt increase in radioactive efflux in response to glibenclamide when perfused in the presence of 1.7, 5.6 and 11.1 mM glucose. The response was most prominent in the presence of 5.6 mM glucose. (2) High glucose cultured islet did not respond to glibenclamide with increased radioactive efflux in the presence of 11.1 mM glucose, in contrast to the effects in the presence of 1.7 or 5.6 mM glucose. The sulphonylurea-induced changes could be delayed by adding glibenclamide in parallel with a decrease in glucose from 20 to 1.7 mM. (3) No effects of glibenclamide on radioactive nucleotide efflux from either low or high glucose cultured islets could be observed in the absence of extracellular Ca2+. (4) Glibenclamide decreased the islet ATP content of low glucose cultured islets in the presence of 5.6 mM glucose. On the contrary, the ATP content of high glucose cultured islets was increased by glibenclamide with 1.7 mM glucose present. (5) Islet respiration was increased by adding glucose in both high or low glucose cultured islets, although respiration in the presence of both 5.6 and 11.1 mM glucose was higher in high glucose cultured islets. (6) The addition of glibenclamide decreased oxygen uptake of low glucose cultured islets in the presence of 5.6 and 11.1 mM glucose and that of high glucose cultured islets at all glucose concentrations tested (1.7, 5.6 and 11.1 mM). It is concluded that glibenclamide-induced changes in radioactive nucleotide efflux may reflect metabolic and ionic changes of importance to islet functions.

Adenine Nucleotides↗

Effect of sensory stimulation on the uptake and incorporation of radioactive lysine into protein of mouse brain and liver.

Alterations in incorporation of tritiated lysine into protein of mouse brain and liver were observed following brief exposure to a variety of sensory stimuli. During a 15-min session, subjects were trained to perform a one-way active avoidance response or else were exposed to one of the stimulus components of the situation, including shocks, buzzers, lights, handling, and the apparatus alone. Twenty min after these behavioral treatments, tritiated lysine was injected subcutaneously, and its incorporation into total protein during a 10-min pulse was measured. Quiet mice, undisturbed until injection of the precursor, constituted the baseline group for biochemical comparisons. Most behavioral treatments increased the total amount of radioactivity in brain and liver. The treatments increased the incorporation of radioactivity into protein of both organs even more, thereby producing elevations of relative radioactivity (RR) of protein, a measure of the amount of radioactivity incorporated into protein relative to that in the acid-soluble pools. The RR increases following most of the behavioral experiences were approximately equal; however, exposure to lights or to the apparatus were less effective than the other treatments in eliciting these metabolic changes. The responses were greatly diminished in mice previously exposed to the treatments. Thus, the effectiveness of a stimulus in producing these metabolic alterations may depend upon its apparent magnitude and its novelty. The total radioactivity increases were larger in brain than in liver, while the RR increases were smaller in brain than in liver. Brain RR increases were of equal magnitude when the precursor was injected 5, 20, or 35 min after behavioral treatment, whereas the liver RR responses declined markedly over this period. Despite these differences, strong positive correlations between brain and liver across the various behavioral treatments existed. The RR changes occurred about equally in the cerebellum-brain stem, basal ganglia, hippocampus-septum, and ventral cortex, while the thalamus-hypothalamus and dorsal cortex showed smaller differences.

Animals↗

Potassium stimulated release of axonally transported radioactivity from slices of rabbit superior colliculus.

The radioactivity in the trichloroacetic acid (TCA) soluble pool in the terminals of the retinal ganglion cells in the superior colliculus (SC) was studied one month after labelling of the nerve cell bodies in the retina with different radioactive amino acids. The TCA soluble fraction in the SC represented a few per cent of the total radioactivity of the isolated tissue and was mainly derived from protein degradation. The perfused slice of the SC responded to high K+ depolarization with an increased release of TCA-soluble radioactivity, while small changes occurred for TCA-precipitable fractions. The evoked release of TCA-soluble radioactivity was particularly prominent after labelling with [3H]glycine. The release was Ca2+-dependent and the response to repetitive depolarization indicated a continuous replenishment of the releasable pool.

Amino Acids↗